Robert W. Baird Upgrades NuVasive To Outperform

Robert W. Baird has upgraded NuVasive NUVA from Neutral to Outperform.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: UpgradesAnalyst RatingsHealth CareHealth Care EquipmentRobert W. Baird
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!